NEOLEUKIN THERAPEUTICS INC (NLTX) Stock Cash Flow
NASDAQ:NLTX - Nasdaq - US64049K2033 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.27M | -57.56M | -60.69M | -33.28M | -69.44M | |||
| Depreciation Amortization | 850.00K | 1.56M | 1.31M | 790.00K | 340.00K | |||
| Change In Working Capital | -5.02M | 890.00K | -700.00K | 970.00K | -1.95M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 6.15M | 9.50M | 12.53M | 6.95M | 55.66M | |||
| OPERATING CASH FLOW | -32.29M | -45.61M | -47.56M | -24.58M | -15.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -650.00K | -1.11M | -3.26M | -2.22M | -880.00K | |||
| Other Investing Activity | 17.81M | -58.02M | N/A | 0.00 | 190.00K | |||
| INVESTING CASH FLOW | 17.15M | -59.13M | -3.26M | -2.22M | -690.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -380.00K | -60.00K | -50.00K | -50.00K | -10.00K | |||
| Stock Issued/Repurchased | 20.00K | 220.00K | 780.00K | 77.54M | 87.77M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -360.00K | -5.53M | |||
| FINANCING CASH FLOW | -340.00K | 160.00K | 730.00K | 77.14M | 82.24M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | 10.00K | |||
| CHANGE IN CASH | -15.48M | -104.58M | -50.09M | 50.34M | 66.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.29M | -45.61M | -47.56M | -24.58M | -15.39M | |||
| Capital Expenditure | -650.00K | -1.11M | -3.26M | -2.22M | -880.00K | |||
| FREE CASH FLOW | -32.94M | -46.72M | -50.82M | -26.80M | -16.27M | |||
All data in USD